Transfusion Medicine - Jeffrey McCullough

Скачать книгу

T, Oikawa S, et al. Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan. Transfusion 2009; 49:2152–2157.

      49 49. Ramirez‐Arcos S, Goldman M. Skin disinfection methods: prospective evaluation and postimplementation results. Transfusion 2010; 50:59–64.

      50 50. McDonald C, McGuane S, Thomas J, et al. A novel rapid and effective donor arm disinfection method. Transfusion 2010; 50:53–58.

      51 51. Reiss RF, Katz AJ. Platelets and factor VIII as functions of blood collection time. Transfusion 1976; 16:229–231.

      52 52. Logic JR, Johnson SA, Smith JJ. Cardiovascular and hematologic responses to phlebotomy in blood donors. Transfusion 1963; 3:83–93.

      53 53. Menke J, Stocker H, Sibrowski W. Cerebral oxygenation and hemodynamic during blood donation studied by near‐infrared spectroscopy. Transfusion 2004; 44:414.

      54 54. Kamel H, Tomasulo P, Bravo M, et al. Delayed adverse reactions to blood donation. Transfusion 2010; 50:556–565.

      55 55. Tomasulo PA, Anderson AJ, Paluso MB, et al. A study of criteria for blood donor deferral. Transfusion 1980; 20:511–518.

      56 56. Goldman M, Osmond L, Yi Q‐L, et al. Frequency and risk factors for donor reactions in an anonymous blood donor survey. Transfusion 2012; 53:1979–1984.

      57 57. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995; 35:734–737.

      58 58. Eder AF, Dy BA, Kennedy JM, et al. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion 2008; 48:1809–1819.

      59 59. Eder AF, Hillyer CD, Dy BA, et al. Adverse reactions to allogeneic whole blood donation by 16‐ and 17‐year olds. JAMA 2008; 299:2279–2286.

      60 60. Newman BH, Newman DT, Ahmad R, Roth AJ. The effect of whole‐blood donor adverse events on blood donor return rates. Transfusion 2006; 46:1374–1379.

      61 61. Popovsky MA. Vasovagal donor reactions: an important issue with implications for the blood supply. Transfusion 2002; 42:1534–1536.

      62 62. Newman BH. Management of young blood donors. Transfus Med Hemother 2014; 41(4):284–295.

      63 63. Wiltbank TB, Giordano GF, Kamel H, et al. Faint and prefaint reactions in whole‐blood donors: an analysis of predonation measurements and their predictive value. Transfusion 2008; 48:1799–1808.

      64 64. Frances CR, Menitove JE. Mitigating adverse reactions in youthful donors. Transfusion 2008; 48:1774–1776.

      65 65. Ando S, Kawamura N, Matsumoto M, et al. Simple standing test predicts and water ingestion prevents vasovagal reaction in the high‐risk blood donors. Transfusion 2009; 49:1630–1636.

      66 66. Frances CR, Rader A, Carison B. Donors who react may not come back: analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions. Transfus Apher Sci 2005; 33:99–106.

      67 67. France CR, France JL, Carlson BW, et al. Fear of blood draws, vasovagal reactions, and retention among high school donors. Transfusion 2014; 54(3):918–924.

      68 68. Rigas A, Pedersen O, Rostgaard K, et al. Frequent blood donation and offspring scholastic attainment—an assessment of long‐term consequences of pre‐natal iron deficiency. Transfusion 2019; 59:1717–1722.

      69 69. Spencer B, Bialkowski W, Creel D, et al. Elevated risk for iron depletion in high school age blood donors. Transfusion 2019; 59:1706–1716.

      70 70. Krumholz A, Ness PM, Hauser WA, et al. Adverse reactions in blood donors with a history of seizures or epilepsy. Transfusion 1995; 35:470–474.

      71 71. Newman BH, Waxman DA. Blood donation‐related neurologic needle injury: evaluation of 2 years’ worth of data from a large blood center. Transfusion 1996; 36:213–215.

      72 72. Berry PR, Wallis WE. Venipuncture nerve injuries. Lancet 1977; 1:1236–1237.

      73 73. Horowitz SH. Venipuncture‐induced causalgia: anatomic relations of upper extremity superficial veins and nerves, and clinical considerations. Transfusion 2000; 40:1036–1040.

      74 74. Newman B. Arm complications after manual whole blood donation and their impact. Transf Med Rev 2013; 27(2):65–73.

      75 75. Covin RB, Rich NL, Aysola A. Upper‐extrmeity deep venous thrombosis complicating whole‐blood donation. Transfusion 2004; 44:586–590.

      76 76. Newman B, Rajpurkar M, Ozgonenel B, et al. Upper‐extremity deep venous thrombosis after whole blood donation: report of three cases from a single blood center. Transfusion 2015; 55(6):1290–1293.

      77 77. Lasky LC, Lin A, Kahn RA, McCullough J. Donor platelet response and product quality assurance in plateletpheresis. Transfusion 1981; 21:247.

      78 78. Glowitz RJ, Slichter SJ. Frequent multiunit plateletpheresis from single donors: effects on donors’ blood and the platelet yield. Transfusion 1980; 20:199–205.

      79 79. Heyns AP, Badenhorst PN, Lotter MG, et al. Kinetics and mobilization from the spleen of indium‐111‐labeled platelets during platelet apheresis. Transfusion 1985; 25:215–218.

      80 80. Page EA, Coppock JE, Harrison JF. Study of iron stores in regular plateletpheresis donors. Transfus Med 2010; 20(1):22–29.

      81 81. Yuan S, Ziman A, Smeltzer B, et al. Moderate and severe adverse events associated with apheresis donations: incidences and risk factors. Transfusion 2010; 50:478–486.

      82 82. Winters JL. Complication of donor apheresis. J Clin Apher 2006; 21:132–141.

      83 83. Strauss RG. Mechanism of adverse effects during hemapheresis. J Clin Apher 1996; 11:160–164.

      84 84. Olson PR, Cox C, McCullough J. Laboratory and clinical effects on the infusion of ACD solution during plateletpheresis. Vox Sang 1977; 33:79–87.

      85 85. Bolan CD, Greer SE, Cecco SA, et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001; 41:1165–1171.

      86 86. Bolan CD, Wesley RA, Yau YY, et al. Randomized placebo‐controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms. Transfusion 2003; 42:1403–1413.

      87 87. Ladenson JH, Miller WV, Sherman LA. Relationship of physical symptoms, ECG, free calcium, and other blood chemistries in reinfusion with citrated blood. Transfusion 1978; 18:670–679.

      88 88. Komatsu F, Shikata M. Abnormal electrocardiographic findings in apheresis donors. Transfusion 1988; 28:371–374.

      89 89. Laspina SJ, Browne MA, McSweeney EN, et al. QTc prolongation in apheresis platelet donors. Transfusion 2002; 42:899–903.

      90 90. Uhl L, Maillet S, King S, Kruskall MS. Unexpected citrate toxicity and severe hypocalcemia during apheresis. Transfusion 1997; 37:1063–1065.

      91 91. Howard JE, Perkins HA. Lysis of donor RBC during plateletpheresis with a blood processor. JAMA 1976; 236:289–290.

      92 92. Kaur D, Kandwal M. Alarmed or unalarmed!! Donor red cell lysis during plateletpheresis procedure. Transfus Apher Sci 2018; 57:277–280.

      93 93. Chao FC, Tullis JL, Tinch J, et al. Plateletpheresis by discontinuous centrifugation: effect of collecting methods on the in vitro function of platelets. Br J Haematol 1979; 39:177–187.

      94 94. Bongiovanni MB, Katz RS, Wurzel HA. Long‐term plateletpheresis of a donor. Transfusion 1980; 20:465–466.

      95 95. Lazarus EF, Browning J, Norman J, et al. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion 2001; 41:756–761.

      96 96. Strauss RG. Effects on donors of repeated leukocyte losses during plateletpheresis. J Clin Apheresis 1994; 9:130–134.

      97 97. Richa E, Krueger P, Burgstaler EA, et al. The effect of double‐ and triple‐apheresis platelet product donation on apheresis donor platelet and white blood cell

Скачать книгу